Epigenetics

Cancer cells
#Drug discovery #Epigenetics #Genomics #Oncology

How Oryzon Genomics is using epigenetics to tackle cancer  

DDW Editor Reece Armstrong speaks to Dr Carlos Buesa, Founder and CEO of Oryzon Genomics, about epigenetic approaches to treating cancer and the company’s current journey within drug discovery and development.   RA: Can an epigenetic approach help tackle aggressive cancers and those with poor prognoses?  CB: Yes. Many aggressive cancers are… Read More

#Exclusive Content

Colon cancer
#Colorectal cancer #Epigenetics #Juntendo University #Oncology

Study reveals how IL-26 reprogrammes colorectal cancer cells

Researchers have identified inflammatory cytokine interleukin-26 (IL-26) as a factor that acts on cancer cells and induces epigenetic reprogramming, promoting immune evasion.  While cancer cells acquire malignant traits through epigenetic remodelling, it remains unclear how immune-derived inflammatory factors regulate the epigenetics of colorectal cancer cells.  … Read More

#Cancer Research #News #Trending News

Antique clock
#Age-related diseases (ARDs) #Ageing #Epigenetics #Healthspan #Multiomics #Rejuvenation therapies

Turning back the epigenetic clock: Can we reverse ageing?

In this article, based on a session at Life Sciences Baltics 2025, Diana Turner reviews the latest research into epigenetics and rejuvenation.  An epigenetic clock is a biomarker of ageing that can be used to estimate ‘biological age’. The method relies on the modifications to DNA that… Read More

#Exclusive Content

#Epigenetics #Genetics / genomics #Oxford Nanopore Technologies #UK Biobank #UK government

UK partners to create world’s largest epigenetic dataset

A world-first ‘epigenetic map’ of the human genome could lead to breakthroughs in new diagnoses and treatments, say UK scientists.  This new resource for medical researchers will be created though a new strategic partnership between the UK government, Oxford Nanopore Technologies, UK Biobank, NHS England and Genomics… Read More

#News #Trending News

#Breast cancer #Cancer research #DNA mutations #Epigenetics #Gene therapy #Oncology

New podcast shining a spotlight on cancer research developments

This is the latest episode of the free DDW narrated podcast, titled “How to utilise clinical trials in drug discovery” which covers two articles written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: The ‘dark matter’ behind cancer and Could this ‘Goldilocks’… Read More

#Cancer Research #News

#Epigenetics #Genomics #Multiomics #Nanopore sequencing #Omics #Proteomics #Transcriptomics

Multiomics sequencing: Find out what you’re missing

Download this new brochure ‘Multiomic nanopore sequencing solutions: Revolutionising human disease research‘ to maximise the data generated from your valuable research samples. Understanding the mechanisms of disease requires complex data ranging from genomic data through to transcriptomics, epigenetics and proteomics. Legacy multiomic approaches require multiple platforms… Read More

#News

#Epigenetics #Genomics #Multiomics #Nanopore sequencing #Omics #Proteomics #Transcriptomics

Multiomics sequencing: How to maximise the data generated from valuable research samples

Understanding the mechanisms of disease requires complex data ranging from genomic data through to transcriptomics, epigenetics and proteomics. Legacy multiomic approaches require multiple platforms and complex processes, which are incompatible with disease research that utilises scarce tissue samples. Download the brochure to learn how multiomic nanopore sequencing can… Read More

#Resources

Cancer cells
#Breast cancer #Drug targets #Epigenetics #Oncology #The Institute of Cancer Research

Research uncovers how to target dormant breast cancer cells

Scientists have discovered how breast cancer cells can ‘hibernate’ to avoid treatment and ‘wake up’ years later – causing a relapse that is more difficult to treat. Their research, published in the journal Cancer Discovery, reveals the role of epigenetics in controlling how cancer cells can… Read More

#Cancer Research #News

#Ageing #Cancer research #Epigenetics #Gene regulation #HKG Epitherapeutics #Precision medicine

The epigenetic edge: Harnessing precision medicine’s potential 

HKG Epitherapeutics is a biotechnology company developing novel tools for the early detection of cancer and promoting healthy aging. Founder Dr Moshe Szyf Founder shares the potential of harnessing precision medicine.  Embarking on a new era of medicine  The advent of genomics has ushered in… Read More

#Business & Investment #Exclusive Content #Opinion

#Cancer research #Cancer treatment #CAR-T #Cell therapy #Drug discovery #Epigenetics #Immunotherapy #Oncology

New episode of the DDW Highlights podcast available

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  As well as providing extensive coverage of the … Read More

#News

#Cancer research #Cancer treatment #CAR-T #Cell therapy #Drug discovery #Epigenetics #Immunotherapy #Oncology

This week in drug discovery (27 February – 3 March)

News round-up for 27 February – 3 March by DDW Digital Content Editor Diana Spencer.  As well as providing extensive coverage of the SLAS2023 meeting in San Diego and Rare Disease Day, DDW has also reported on a… Read More

#News

Research in genetics laboratory
#Cancer research #Epigenetics #Gene expression #Genetics / genomics #Oncology #The Institute of Cancer Research

Epigenetics discovery could lead to new class of cancer drugs

A new paper has solved the 20-year mystery of how epigenetic modifications act as traffic lights to control gene expression and could ultimately speed up the development of a new class of epigenetic cancer drugs.  Epigenetics is still largely unexplored and referred to as the ‘dark matter’… Read More

#Cancer Research #Editor's Choice #News

DNA unwinding from histones
#Cancer research #DNA mutations #Epigenetics #Oncology

The ‘dark matter’ behind cancer

Listen to this article on the DDW Podcast: DDW Editor Reece Armstrong looks into recent research which may explain why cancers can become more aggressive. Researchers in London and Milan may have discovered why cancers can become more aggressive without relying only on DNA mutations. A lot… Read More

#Cancer Research #Exclusive Content

#Cancer #Cancer research #Cancer vaccine #Chemotherapy #Chemotherapy-resistance #Drug resistance #Epigenetics #Oncology #Personalised medicine

Cancer research drugs: Where is the innovation?

An update on the latest oncology developments by DDW Digital Content Editor Diana Spencer The last month has seen huge strides forward in our understanding of cancers, particularly in how they develop resistance to therapies and how we can ‘outsmart’ them using gene editing or different therapeutic pathways, but also… Read More

#Cancer Research #Editor's Choice #News

Genetic engineering
#Bowel cancer #Cancer #Cancer research #DNA #DNA mutations #Epigenetics #Oncology #Treatment outcomes

Epigenetics vital in predicting cancer drug outcomes 

Cancers can evolve to become more aggressive without relying only on DNA mutations, two major studies have revealed.  The research characterises an extra level of control of cancer gene activity within tumours, which the researchers describe as cancer’s ‘dark matter’.  The two studies showed how… Read More

#Cancer Research #News